Literature DB >> 31852692

Late ventricular standstill following an elective TAVI.

Peter Wheen1, Richard Armstrong2, Andrew Maree2, Stephen O'Connor2.   

Abstract

Transcatheter aortic valve implantations (TAVIs) may be complicated by a need for permanent pacemaker implantation post procedure, usually due to local trauma or compression on the conduction system. There are some features that might help predict that a patient is high risk for developing conduction disease following TAVI, for example, underlying right bundle branch block or use of certain types of TAVI. It might also become apparent during the procedure, or before temporary wire removal post procedure. Higher risk patients may undergo rhythm monitoring for longer periods post TAVI. We present a case where a patient required an unexpected emergency pacemaker following a TAVI, despite low risk clinical features, a low risk baseline ECG, and the use of a low risk TAVI valve. In addition, this very significant conduction disease only became apparent over 72 hours following implantation, despite normal resting ECGs and telemetry up to that point. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  arrhythmias; interventional cardiology; pacing and electrophysiology; valvar diseases

Mesh:

Year:  2019        PMID: 31852692      PMCID: PMC6936433          DOI: 10.1136/bcr-2019-232477

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion.

Authors:  Kevin L Greason; Paul A Friedman; Daniel R Brown; Verghese Mathew
Journal:  J Thorac Cardiovasc Surg       Date:  2014-10-05       Impact factor: 5.209

2.  Delayed pacemaker requirement after transcatheter aortic valve implantation with a new-generation balloon expandable valve: Should we monitor longer?

Authors:  Fernando De-Torres-Alba; Gerrit Kaleschke; Julia Vormbrock; Stefan Orwat; Robert Radke; Monika Feurle; Gerhard-Paul Diller; Holger Reinecke; Helmut Baumgartner
Journal:  Int J Cardiol       Date:  2018-07-26       Impact factor: 4.164

3.  Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantation.

Authors:  Buntaro Fujita; Maximilian Kütting; Moritz Seiffert; Smita Scholtz; Sandrine Egron; Emir Prashovikj; Jochen Börgermann; Timm Schäfer; Werner Scholtz; Rainer Preuss; Jan Gummert; Ulrich Steinseifer; Stephan M Ensminger
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2016-01-12       Impact factor: 6.875

4.  The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study.

Authors:  David A Wood; Sandra B Lauck; John A Cairns; Karin H Humphries; Richard Cook; Robert Welsh; Jonathon Leipsic; Philippe Genereux; Robert Moss; John Jue; Philipp Blanke; Anson Cheung; Jian Ye; Danny Dvir; Hamed Umedaly; Rael Klein; Kevin Rondi; Rohan Poulter; Dion Stub; Marco Barbanti; Peter Fahmy; Nay Htun; Dale Murdoch; Roshan Prakash; Madeleine Barker; Kevin Nickel; Jay Thakkar; Janarthanan Sathananthan; Ben Tyrell; Faisal Al-Qoofi; James L Velianou; Madhu K Natarajan; Harindra C Wijeysundera; Sam Radhakrishnan; Eric Horlick; Mark Osten; Christopher Buller; Mark Peterson; Anita Asgar; Donald Palisaitis; Jean-Bernard Masson; Susheel Kodali; Tamim Nazif; Vinod Thourani; Vasilis C Babaliaros; David J Cohen; Julie E Park; Martin B Leon; John G Webb
Journal:  JACC Cardiovasc Interv       Date:  2019-03-11       Impact factor: 11.195

5.  Autopsy finding of the Sapien XT valve from a patient who died suddenly after transcatheter aortic valve replacement.

Authors:  Mike Saji; Tatsuya Murai; Tetsuya Tobaru; Minoru Tabata; Shuichiro Takanashi; Morimasa Takayama
Journal:  Cardiovasc Interv Ther       Date:  2013-01-01

6.  Very low pacemaker rate following ACURATE neo transcatheter heart valve implantation.

Authors:  Stefan Toggweiler; Henrik Nissen; Brynjolfur Mogensen; Florim Cuculi; Christian Fallesen; Karsten Tange Veien; Miriam Brinkert; Richard Kobza; Andreas Rück
Journal:  EuroIntervention       Date:  2017-12-20       Impact factor: 6.534

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.